Mengdong He

557 total citations
19 papers, 351 citations indexed

About

Mengdong He is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Mengdong He has authored 19 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Epidemiology. Recurrent topics in Mengdong He's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Advanced Causal Inference Techniques (3 papers) and Statistical Methods in Clinical Trials (3 papers). Mengdong He is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Advanced Causal Inference Techniques (3 papers) and Statistical Methods in Clinical Trials (3 papers). Mengdong He collaborates with scholars based in United States, Spain and United Kingdom. Mengdong He's co-authors include Joshua J. Gagne, Katsiaryna Bykov, Yinzhu Jin, Brian T. Bateman, Hemin Lee, Ameet Sarpatwari, Aaron S. Kesselheim, Reed F. Beall, Seoyoung C. Kim and Sara Karami and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Epidemiology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Mengdong He

19 papers receiving 342 citations

Peers

Mengdong He
Nileesa Gautam United States
Randa Eldessouki Egypt
Anat Fisher Canada
Cathy Anne Pinto United States
Cornelis Biesheuvel Australia
Ruben G. Duijnhoven Netherlands
Mugdha Gokhale United States
Josh Benner United States
Karin Sennfält Sweden
Nasrin Mansournia Iran
Nileesa Gautam United States
Mengdong He
Citations per year, relative to Mengdong He Mengdong He (= 1×) peers Nileesa Gautam

Countries citing papers authored by Mengdong He

Since Specialization
Citations

This map shows the geographic impact of Mengdong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengdong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengdong He more than expected).

Fields of papers citing papers by Mengdong He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengdong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengdong He. The network helps show where Mengdong He may publish in the future.

Co-authorship network of co-authors of Mengdong He

This figure shows the co-authorship network connecting the top 25 collaborators of Mengdong He. A scholar is included among the top collaborators of Mengdong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengdong He. Mengdong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
D’Andrea, Elvira, Rishi Desai, Mengdong He, et al.. (2022). Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis. Journal of the American College of Cardiology. 80(1). 36–46. 21 indexed citations
2.
Lee, Hemin, Nileesa Gautam, Seanna Vine, et al.. (2022). Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study. Clinical and Experimental Rheumatology. 41(1). 110–117. 4 indexed citations
3.
He, Mengdong, Ajinkya Pawar, Rishi Desai, et al.. (2021). Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study. Seminars in Arthritis and Rheumatism. 51(6). 1242–1250. 11 indexed citations
4.
Pawar, Ajinkya, Rishi Desai, Mengdong He, Lily G. Bessette, & Seoyoung C. Kim. (2021). Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drugs. ACR Open Rheumatology. 3(8). 531–539. 7 indexed citations
5.
Lee, Hemin, Mengdong He, Soo‐Kyung Cho, et al.. (2021). Validation of claims‐based algorithms to identify patients with psoriasis. Pharmacoepidemiology and Drug Safety. 30(7). 868–874. 6 indexed citations
6.
Bykov, Katsiaryna, Elisabetta Patorno, Elvira D’Andrea, et al.. (2021). Prevalence of Avoidable and Bias‐Inflicting Methodological Pitfalls in Real‐World Studies of Medication Safety and Effectiveness. Clinical Pharmacology & Therapeutics. 111(1). 209–217. 22 indexed citations
7.
Lauffenburger, Julie C., et al.. (2021). Impact of implementing electronic prior authorization on medication filling in an electronic health record system in a large healthcare system. Journal of the American Medical Informatics Association. 28(10). 2233–2240. 11 indexed citations
8.
Sarpatwari, Ameet, et al.. (2020). Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) Program. Drug Safety. 44(3). 327–335. 5 indexed citations
9.
He, Mengdong, Krista F. Huybrechts, Sara Z. Dejene, et al.. (2020). Validation of algorithms to identify adverse perinatal outcomes in the Medicaid Analytic Extract database. Pharmacoepidemiology and Drug Safety. 29(4). 419–426. 21 indexed citations
10.
Lipsitch, Marc, Brian T. Bateman, Mengdong He, et al.. (2020). Association Between Congenital Cytomegalovirus and the Prevalence at Birth of Microcephaly in the United States. JAMA Pediatrics. 174(12). 1159–1159. 33 indexed citations
11.
Bykov, Katsiaryna, Mengdong He, & Joshua J. Gagne. (2020). Trends in Utilization of Prescribed Controlled Substances in US Commercially Insured Adults, 2004-2019. JAMA Internal Medicine. 180(7). 1006–1006. 14 indexed citations
12.
He, Mengdong, et al.. (2019). PBI40 ICD-9 TO ICD-10 MAPPING FOR RESEARCH IN BIOLOGICS AND BIOSIMILARS USING ADMINISTRATIVE HEALTHCARE DATA. Value in Health. 22. S55–S55. 1 indexed citations
13.
Bykov, Katsiaryna, Mengdong He, Jessica M. Franklin, et al.. (2019). Glucose‐lowering medications and the risk of cancer: A methodological review of studies based on real‐world data. Diabetes Obesity and Metabolism. 21(9). 2029–2038. 17 indexed citations
14.
He, Mengdong, Adrian J. Santiago Ortiz, James Marshall, et al.. (2019). Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data. Pharmacoepidemiology and Drug Safety. 29(7). 770–777. 7 indexed citations
15.
Sarpatwari, Ameet, et al.. (2018). Evaluating The Impact Of The Orphan Drug Act’s Seven-Year Market Exclusivity Period. Health Affairs. 37(5). 732–737. 40 indexed citations
16.
Dong, Yaa‐Hui, et al.. (2018). Use of olmesartan and enteropathy outcomes: a multi‐database study. Alimentary Pharmacology & Therapeutics. 47(6). 792–800. 22 indexed citations
17.
Gagne, Joshua J., Mengdong He, & Brian T. Bateman. (2018). Trends in Opioid Prescription in Children and Adolescents in a Commercially Insured Population in the United States, 2004-2017. JAMA Pediatrics. 173(1). 98–98. 14 indexed citations
18.
Wang, Shirley, Yinzhu Jin, Bruce Fireman, et al.. (2018). Relative Performance of Propensity Score Matching Strategies for Subgroup Analyses. American Journal of Epidemiology. 187(8). 1799–1807. 77 indexed citations
19.
Wang, Shirley, Mengdong He, Yinzhu Jin, et al.. (2017). A review of the performance of different methods for propensity score matched subgroup analyses and a summary of their application in peer‐reviewed research studies. Pharmacoepidemiology and Drug Safety. 26(12). 1507–1512. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nileesa Gautam Breakdown of academic impact, for papers by Randa Eldessouki Breakdown of academic impact, for papers by Anat Fisher Breakdown of academic impact, for papers by Cathy Anne Pinto Breakdown of academic impact, for papers by Cornelis Biesheuvel Breakdown of academic impact, for papers by Ruben G. Duijnhoven Breakdown of academic impact, for papers by Mugdha Gokhale Breakdown of academic impact, for papers by Josh Benner Breakdown of academic impact, for papers by Karin Sennfält Breakdown of academic impact, for papers by Nasrin Mansournia
Rankless by CCL
2026